Your browser doesn't support javascript.
loading
Barriers to Referral for Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Identified Using a Tailoring Grid Methodology: Interviews with Stakeholders in New York State.
Francescutti, Valerie A; Skitzki, Joseph J; Kane, John M; Simunovic, Marko.
Afiliação
  • Francescutti VA; Division of General Surgery, Department of Surgery, McMaster University and Juravinski Cancer Center, Hamilton, Ontario, Canada.. Electronic address: francesv@hhsc.ca.
  • Skitzki JJ; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Kane JM; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Simunovic M; Division of General Surgery, Department of Surgery, McMaster University and Juravinski Cancer Center, Hamilton, Ontario, Canada.
J Surg Res ; 267: 235-242, 2021 11.
Article em En | MEDLINE | ID: mdl-34157492
ABSTRACT

INTRODUCTION:

Cytoreduction and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) has variable uptake, with referrals reliant on other physicians. To characterize barriers to referral for CS/HIPEC, we created a pragmatic "tailoring grid", incorporating the concepts of Pathman's 4 As of awareness, agreement, adoption, and adherence and barriers acting at the individual, practice group, and organization level. METHODS AND MATERIALS We invited surgeons and medical oncologists from Western New York State who potentially refer patients for CS/HIPEC to participate in tailoring grid interviews.

RESULTS:

Interviews of 10 surgeons and 10 medical oncologists were completed. The participants were positioned in the Pathman 4 A's with respect to referrals for CS/HIPEC as follows (1) A 19 aware (1 not aware); (2) A 3 in agreement (17 not in agreement); (3) A 9 adopters; and (4) A 6 adherent. Among the 9 participants who had referred at least one patient for CS/HIPEC (adopters/adherent), only 2 were in agreement with the appropriateness of CS/HIPEC. Barriers to awareness of included lack of interaction with colleagues and knowledge of indications. Barriers to agreement included lack of high quality of evidence supporting CS/HIPEC such as well-designed RCTs. Barriers to adoption included lack of communication with CS/HIPEC surgeons; lack of inclusion of the procedure into algorithms and defined morbidity/mortality rates. Barriers to adherence included lack of inclusion into guidelines by major societies; perceptions that the procedure is resource-intensive; lack of defined quality measures.

CONCLUSIONS:

The tailoring grid efficiently identified barriers to awareness, agreement, adoption and adherence for routine referral for CS/HIPEC. Barriers to increased referrals included lack of high-quality evidence supporting CS/HIPEC. Barriers more easily addressed included communication between referring and CS/HIPEC surgeons, and outcomes at the individual patient and hospital level.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Hipertermia Induzida Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Hipertermia Induzida Idioma: En Ano de publicação: 2021 Tipo de documento: Article